These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 23116312)

  • 1. Perspectives on new synthetic curcumin analogs and their potential anticancer properties.
    Vyas A; Dandawate P; Padhye S; Ahmad A; Sarkar F
    Curr Pharm Des; 2013; 19(11):2047-69. PubMed ID: 23116312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in studying curcumin and its nano-preparations for cancer therapy.
    Liu J; Chen S; Lv L; Song L; Guo S; Huang S
    Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical applications of curcumin: current state and the future.
    Fan X; Zhang C; Liu DB; Yan J; Liang HP
    Curr Pharm Des; 2013; 19(11):2011-31. PubMed ID: 23116310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin nanomedicine: a road to cancer therapeutics.
    Yallapu MM; Jaggi M; Chauhan SC
    Curr Pharm Des; 2013; 19(11):1994-2010. PubMed ID: 23116309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin and its formulations: potential anti-cancer agents.
    Ji JL; Huang XF; Zhu HL
    Anticancer Agents Med Chem; 2012 Mar; 12(3):210-8. PubMed ID: 22044005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs).
    Zhao C; Liu Z; Liang G
    Curr Pharm Des; 2013; 19(11):2114-35. PubMed ID: 23116317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
    Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
    Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral bioavailability of curcumin: problems and advancements.
    Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G
    J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.
    Sarkar FH; Li Y; Wang Z; Padhye S
    Curr Pharm Des; 2010 Jun; 16(16):1801-12. PubMed ID: 20345353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal curcumin and its application in cancer.
    Feng T; Wei Y; Lee RJ; Zhao L
    Int J Nanomedicine; 2017; 12():6027-6044. PubMed ID: 28860764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of curcumin and medicinal effects of the copper(II)-curcumin complexes.
    Leung MH; Harada T; Kee TW
    Curr Pharm Des; 2013; 19(11):2070-83. PubMed ID: 23116313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers.
    Mbese Z; Khwaza V; Aderibigbe BA
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31801262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on Curcuma as a functional food in the control of cancer and inflammation.
    Schaffer M; Schaffer PM; Bar-Sela G
    Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin and Cancer.
    Giordano A; Tommonaro G
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31590362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin: the Indian solid gold.
    Aggarwal BB; Sundaram C; Malani N; Ichikawa H
    Adv Exp Med Biol; 2007; 595():1-75. PubMed ID: 17569205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin and Melanoma: From Chemistry to Medicine.
    Nabavi SM; Russo GL; Tedesco I; Daglia M; Orhan IE; Nabavi SF; Bishayee A; Nagulapalli Venkata KC; Abdollahi M; Hajheydari Z
    Nutr Cancer; 2018; 70(2):164-175. PubMed ID: 29300102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstacles against the Marketing of Curcumin as a Drug.
    Hassanzadeh K; Buccarello L; Dragotto J; Mohammadi A; Corbo M; Feligioni M
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry.
    Padhye S; Chavan D; Pandey S; Deshpande J; Swamy KV; Sarkar FH
    Mini Rev Med Chem; 2010 May; 10(5):372-87. PubMed ID: 20370702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological effects of curcumin and its role in cancer chemoprevention and therapy.
    Singh S; Khar A
    Anticancer Agents Med Chem; 2006 May; 6(3):259-70. PubMed ID: 16712454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective of curcumin, a pleiotropic signalling molecule from Curcuma longa in the treatment of Glioblastoma.
    Luthra PM; Lal N
    Eur J Med Chem; 2016 Feb; 109():23-35. PubMed ID: 26748069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.